← Back to Clinical Trials
Recruiting NCT06142032

NCT06142032 Support Groups in the Metaverse for Ukrainian Refugees

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06142032
Status Recruiting
Phase
Sponsor University of Bucharest
Condition Mental Health Wellness 1
Study Type INTERVENTIONAL
Enrollment 45 participants
Start Date 2023-12-20
Primary Completion 2025-04

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 85 Years
Study Type INTERVENTIONAL
Interventions
Metaverse support groupIn-Person support group

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 45 participants in total. It began in 2023-12-20 with a primary completion date of 2025-04.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this clinical trial is to test the efficacy of support groups held in the Metaverse, designed to promote mental health and well-being in Ukrainian refugees. Participants: * will be allocated to one of three conditions: (1) Metaverse support group (intervention); (2) In-Person support group (intervention); or (3) Waitlist. * will be asked to participate in 5 support group sessions, once per week, for each intervention condition. The Metaverse support groups will be compared with the In-Person support groups and with the Waitlist, to test: * the efficacy of the Metaverse condition compared to the In-Person condition. * the efficacy of the intervention conditions compared to the waitlist.

Eligibility Criteria

Inclusion Criteria: \- Part of Ukrainian refugee communities Exclusion Criteria: * Younger than 18. * Not part of the Ukrainian refugee community. * Formally diagnosed with a mental disorder. * PTSD * Currently participating in any ongoing therapeutic intervention or treatment for mental health.

Contact & Investigator

Central Contact

Cezar Giosan, PhD

✉ giosan@outlook.com

📞 +40730908050

Principal Investigator

Cezar Giosan, PhD

PRINCIPAL INVESTIGATOR

University of Bucharest

Frequently Asked Questions

Who can join the NCT06142032 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 85 Years, studying Mental Health Wellness 1. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06142032 currently recruiting?

Yes, NCT06142032 is actively recruiting participants. Contact the research team at giosan@outlook.com for enrollment information.

Where is the NCT06142032 trial being conducted?

This trial is being conducted at Bucharest, Romania.

Who is sponsoring the NCT06142032 clinical trial?

NCT06142032 is sponsored by University of Bucharest. The principal investigator is Cezar Giosan, PhD at University of Bucharest. The trial plans to enroll 45 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology